The science of vaccine development is entering a new frontier due to scientists’ realization that they can target a virus’ ...

Two RSV vaccines have been approved for use in the U.S. in older adults, Arexvy and Abrysvo, and we’re entering our first respiratory virus season where these shots are available. RSV season usually ...

GSK has received approval from Japan’s MHLW for RSV vaccine Arexvy to prevent RSV disease in adults aged over 60 years ...

GSK plc has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its Arexvy (respiratory ...

New Scientist explains how the latest covid-19 booster vaccines are different from previous ones, and who should get them ...

For the first time, the U.S. has vaccines to fight a trio of viruses that cause fall and winter misery. But health officials ...

The way has been largely cleared for the rollout of Pfizer’s respiratory syncytial virus (RSV) vaccine to help protect ...

Updated COVID-19 vaccines are being rolled out in the U.S., aimed at targeting the latest, prevalent variants of the disease.

WASHINGTON — U.S. regulators on Monday approved the first RSV vaccine for pregnant women so their babies will be born with protection against the scary respiratory infection. RSV is notorious ...

GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare ...

Pfizer’s respiratory syncytial virus (RSV) vaccine, Abrysvo, that can help to protect infants through the active immunisation of pregnant women, has been backed by the US Centers for Disease Control ...

U.S. health officials are recommending RSV vaccinations for moms-to-be as a second option to protect newborns. The Centers ...